NEW YORK, July 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021

http://www.reportlinker.com/p0572966/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Navigation_Systems

Do you want to discover the opportunities there?

What are the commercial prospects for pharmaceutical anti-counterfeiting technology? Our new report shows you that industry and market's revenue potential from 2011 to 2021.

There, you will assess anti-counterfeiting technologies, seeing trends and opportunities. We aim to save you time and aid your decisions through our research, analysis and discussions. 

Our report shows you revenue prospects for pharma anti-counterfeiting technologies at total world, submarket and national levels to 2021. We discuss the anti-counterfeiting activities of companies such as Pfizer, J&J, GSK, Sanofi-Aventis, Novartis and AstraZeneca. 

We also discuss the activities and potential of anti-counterfeiting specialists, such as NanoGuardian, Ahura Scientific, TruTag Technologies, Colorcon, Authentix, 3M, Cortegra and Covectra.

Our study forecasts revenues for radio frequency identification (RFID), pharmaceutical taggant, hologram/OVD, security ink and watermark technologies to 2021. You will see their market potentials.

Which pharma anti-counterfeiting technologies and national markets will provide the best opportunities from 2011 to 2021? What effects will governmental policies have? Our work gives answers you need. 

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now. 

Industry and market analysis to help your work - so you won't be left behind

Our report gives you revenue forecasts, growth rates and market shares. We also provide a SWOT/STEP analysis, review of companies and product developments, and opinions from our survey. 

We include 67 tables and charts and three research interviews (shown in the accompanying lists). Our study helps you to understand pharma anti-counterfeiting activities this decade.

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021 shows you revenue trends, opportunities and challenges

Our report gives you the following advantages:

• You will receive hard data for the pharmaceutical anti-counterfeiting industry and market from 2010 to 2021

• You will discover revenue forecasting for the overall world market to 2021

• You will see revenue predictions for leading technologies - RFID, taggants, holograms/OVDs, security inks and watermarks - to 2021

• You will assess anti-counterfeiting needs at world and regional level

• You will find revenue predictions for leading geographical markets to 2021 (US, UK, Germany, France, Japan, Italy, Canada, Spain, China and India)

• You will assess the implications of government mandates for product serialisation, seeing how these will affect the activities of pharma companies

• You will assess leading companies in pharma anti-counterfeiting, discovering their activities, potential and commercial outlooks for the future

• You will examine research and development, as well as up-and-coming technologies for tackling drug counterfeiting

• You will investigate competition and opportunities that will influence revenues

• You will see what will stimulate and restrain the industry and market

• You will analyse opportunities for established companies and those seeking to enter the anti-counterfeiting technologies market

• You will view opinion from our survey, including full interview transcripts.

That mix of quantitative and qualitative market analysis sets our report apart. Our analysis helps you to stay ahead in commercial knowledge.

Order our report now to gain industry and market information you need

Our report can benefit everybody interested in pharmaceutical anti-counterfeiting technologies. We give predictions and answers you need. Don't miss out - please order our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

NB: All visiongain reports are password locked so please let us know what licence is most suitable for your business needs

Table of Contents

1. Executive Summary

1.1 Review of the Pharmaceutical Anti-counterfeiting Technologies Market

1.2 Aims, Scope and Format of Report

1.3 Research and Analysis Methods

2. Introduction to Drug Counterfeiting

2.1 Pharmaceutical Drug Counterfeiting 

2.2 How Are Drugs Counterfeited?

2.2.1 Motivations for Drug Counterfeiting

2.2.2 Methods for Producing Counterfeit Drugs 

2.2.3 Moving Counterfeit Drugs into the Supply Chain

2.2.4 The Pharmaceutical Distribution System and Corruption

2.2.5 Online Pharmacies and Drug Counterfeiting

2.2.6 Verifying the Authenticity of Online Pharmacies

2.3 The Global Costs of Drug Counterfeiting

2.3.1 The Effects of Counterfeit Drugs on Consumers

2.3.2 The Effects of Counterfeit Drugs on Manufacturers

2.3.3 The Effects of Counterfeit Drugs on Healthcare Providers

2.3.4 The Effects of Counterfeit Drugs on Governments

2.4 Drivers of Drug Counterfeiting 

2.4.1 Drug Counterfeiting Thrives on the Lack of Adequate or Enforceable Legislation

2.4.2 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting

2.4.3 The Inappropriate Use of Drugs Creates a Market for the Supply of Counterfeit Medicines

2.5 Action Taken by Pharmaceutical Companies in the Fight against Drug Counterfeiting 

2.5.1 Introduction

2.5.2 Pfizer

2.5.3 Johnson & Johnson

2.5.4 GlaxoSmithKline

2.5.5 Sanofi-Aventis

2.5.6 Novartis

2.5.7 AstraZeneca

3. Anti-counterfeiting Technologies and Leading Manufacturers, 2011

3.1 Introduction 

3.2 Major Anti-counterfeiting Technologies, 2011

3.2.1 Visual Inspection as the First Line of Defence against Drug Counterfeiting

3.2.2 Holograms as Anti-counterfeiting Technologies

3.2.3 Security Printing as an Anti-counterfeiting Technology

3.2.4 Taggants as Anti-counterfeiting Technologies

3.2.5 Radio Frequency Identification (RFID) as an Anti-counterfeiting Technology 

3.3 Leading Manufacturers of Anti-counterfeiting Technologies

3.3.1 NanoGuardian

3.3.1.1 The NanoEncryption Process

3.3.1.2 NanoGuardian Closed-Loop Protection System

3.3.1.3 NanoGuardian's Global Collaboration Agreement with Capsugel

3.3.2 Ahura Scientific

3.3.2.1 Ahura Scientific's TruScan Technology

3.3.3 TruTag Technologies

3.3.3.1 TruTag's Proprietary Technology

3.3.4 Colorcon

3.3.4.1 Colorcon Brand Enhancement Service

3.3.4.2 Colorcon's Taggants: On-Dose ID

3.3.4.3 Other Identifiers by Colorcon

3.3.5 Authentix

3.3.5.1 The Brand Protection Solutions of Authentix

3.3.5.2 The Packaging Solutions of Authentix

3.3.5.3 Authentix Track-and-Trace Solutions

3.3.6 3M

3.3.6.1 The Anti-counterfeiting Solutions of 3M

3.3.7 Cortegra

3.3.7.1 Cortegra's Item-Level-Serialisation

3.3.8 Covectra

3.3.8.1 Covectra's Authenti-Track Platform

4. Summary of the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021

4.1 Overview of the World Anti-counterfeiting Technologies Market, 2010-2021

4.2 Anti-counterfeiting Technologies Market Will See Growth in Size, 2010-2021

4.2.1 Sales of Anti-counterfeiting Technologies Will Increase in the Leading National Markets

4.2.2 RFID Market is Expected to Show Significant Growth Potential

4.3 Drug Counterfeiting Will Persist at Relatively High Levels in Developing Countries

5. Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021

5.1 The Pharmaceutical Anti-counterfeiting Technologies Market in 2010

5.2 Sales Forecast for the Global Anti-counterfeiting Technologies Market, 2010-2021

5.2.1 Government Mandates Will Promote Growth in the Anti-counterfeiting Technologies Market, 2010-2015

5.2.2 Anti-counterfeiting Technologies Market Will Continue to Grow, 2016-2021

5.3 Sales Revenues for the Leading Anti-counterfeiting Technologies, 2010-2021

5.4 Pharmaceutical RFID Market, 2010-2021

5.4.1 Pharmaceutical RFID Market, 2010

5.4.2 Pharmaceutical RFID Market, 2010-2015

5.4.3 Pharmaceutical RFID Market, 2016-2021

5.5 Pharmaceutical Taggants Market, 2010-2021

5.5.1 Pharmaceutical Taggants Market, 2010

5.5.2 Pharmaceutical Taggants Market, 2010-2015

5.5.3 Pharmaceutical Taggants Market, 2016-2021

5.6 Pharmaceutical Hologram/OVD Market, 2010-2021

5.6.1 Pharmaceutical Hologram/OVD Market, 2010 

5.6.2 Pharmaceutical Hologram/OVD Market, 2010-2015 

5.6.3 Pharmaceutical Hologram/OVD Market, 2016-2021 

5.7 Pharmaceutical Security Inks Market, 2010-2021 

5.7.1 Pharmaceutical Security Inks Market, 2010 

5.7.2 Pharmaceutical Security Inks Market, 2010-2015 

5.7.3 Pharmaceutical Security Inks Market, 2016-2021 

5.8 Pharmaceutical Watermarks Market, 2010-2021 

5.8.1 Pharmaceutical Watermarks Market, 2010 

5.8.2 Pharmaceutical Watermarks Market, 2010-2015 

5.8.3 Pharmaceutical Watermarks Market, 2016-2021

6. Leading National Markets for Anti-counterfeiting Technologies, 2011-2021

6.1 Percentage Share of Counterfeiting Incidents by Region, 2008

6.2 Leading National Markets for the Sale of Anti-counterfeiting Technologies, 2010

6.3 Forecasts for the Leading National Markets, 2010-2021

6.3.1 The US Anti-counterfeiting Technologies Market, 2010-2021

6.3.2 Leading European Anti-counterfeiting Technologies Markets, 2010-2021 

6.3.3 The Japanese Anti-counterfeiting Technologies Market, 2010-2021 

6.3.4 The Canadian Anti-counterfeiting Technologies Market, 2010-2021 

6.3.5 The Chinese Anti-counterfeiting Technologies Market, 2010-2021 

6.3.6 The Indian Anti-counterfeiting Technologies Market, 2010-2021

7. Analysis of the Factors Influencing the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021

7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market

7.2 Market Drivers for the Pharmaceutical Anti-counterfeiting Technologies Market

7.2.1 Public Awareness of the Scale of Drug Counterfeiting

7.2.2 Pharmaceutical Theft

7.2.3 Manufacturer and Distributor Liability for Counterfeit Products

7.2.4 New Supply Chain Security Legislation

7.3 Restraints on the Pharmaceutical Anti-counterfeiting Technologies Market

7.3.1 Lack of Industry-Wide Standards Will Impede Adoption of RFID Technology

7.3.2 Unproven Commercial Benefits of Anti-counterfeiting Technologies

7.3.2.1 Which Metrics can be Used to Prove the Commercial Benefits of Anti-counterfeiting Technologies?

7.3.3 Anti-counterfeiting Technologies to Prevent Online Fraud?

7.3.4 Maintaining Good Anti-counterfeiting Technologies Requires Investment

7.4 Outlook for the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021

7.4.1 Prevention Alongside Detection

7.4.2 The Link between Drug Pricing and Counterfeiting

7.4.3 Parallel Trade in Europe

8. Research Interviews with Leading Experts

8.1 Interview with Katherine Eban, Investigative Journalist, Author of 'Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America's Drug Supply', New York, USA

8.1.1 Drug Counterfeiting and the Challenges faced by Regulators

8.1.2 Extent of Drug Counterfeiting in the USA

8.1.3 Future Challenges in Combating Drug Counterfeiting

8.1.4 The Role of Consumer Education in Combating Drug Counterfeiting

8.1.5 The Role of Technology in Combating Drug Counterfeiting 

8.1.6 Outlook for the Pharmaceutical Anti-counterfeiting Market

8.1.7 Final Thoughts

8.2 Interview with Professor David Bear (Founder and Chief Medical Officer) and Steve Wood (President and CEO), Covectra, Massachusetts, USA

8.2.1 Efforts Being Made by the Pharmaceutical Industry to Secure the Drug Supply Chain

8.2.2 Key Drivers for the Global Adoption of Anti-counterfeiting Technologies

8.2.3 Barriers to an Industry-Wide Adoption of RFID Technologies

8.2.4 Covectra's Response to E-Pedigree Legislation

8.2.5 Feasibility of Adopting 2D Barcoding across the Drug Supply Chain

8.2.6 Integration of Anti-counterfeiting Technologies into Existing Production Lines

8.2.7 Covectra's Proprietary Technologies

8.3 Interview with Grace Rusi Woo, Massachusetts Institute of Technology (MIT), USA

8.3.1 The Bokode

8.3.2 Applications of the Bokode

8.3.3 Commercial Viability of the Bokode Technology and its Widespread Use

9. Outlook for the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021 

9.1 Lack of Concerted Pressure from all Stakeholders is Inadvertently Facilitating Drug Counterfeiting

9.2 Track-and-Trace Technologies Will Drive Market Growth

9.3 What Steps Can Pharmaceutical Companies take to Combat Drug Counterfeiting?

9.3.1 Greater Transparency in Reporting Cases of Drug Counterfeiting

9.3.2 Drug Pricing and the Funding of National Drug Regulatory Authorities

9.4 The Role of the International Community in Combating Drug Counterfeiting

9.4.1 Improved Inter-governmental Cooperation in Anti-counterfeiting Strategies

9.4.2 Regulatory Agencies should be Given Greater Powers

9.5 Regulating the Internet

9.6 Counterfeit Drugs from China 

9.7 Some Promising Technologies for Combating Drug Counterfeiting

9.7.1 Bokode

9.7.2 SigNature DNA

9.7.3 WISeAuthentic 

9.7.4 N.O.t.E.S

10. Conclusions 

10.1 The World Anti-counterfeiting Technologies Market Will Experience Rapid Growth from 2010-2015

10.2 The US Will Continue to Dominate the Global Anti-counterfeiting Technologies Market

10.3 Datamatrix Labels Will Remain Competitive with RFID Tags

10.4 The Effects of Government Mandates on the Uptake of Anti-counterfeiting Technologies

10.4.1 The Situation in Developed Countries

10.4.2 The Situation in Developing Countries

List of Tables

Table 2.1 Worldwide Incidents of Drug Counterfeiting, 2002-2009

Table 3.1 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2011

Table 3.2 Leading Manufacturers of Anti-counterfeiting Security Inks, 2011

Table 3.3 Leading Manufacturers of Pharmaceutical Taggants, 2011

Table 3.4 Leading Manufacturers of RFID Tags, 2011

Table 4.1 Market Revenues ($m) and Market Shares (%) for the RFID Technology, 2011-2021

Table 5.1 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2010-2015

Table 5.2 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2016-2021

Table 5.3 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2010-2015

Table 5.4 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2016-2021

Table 5.5 International Patent Applications for RFID Technologies by Country of Origin (%), 2000-2010

Table 5.6 Pharmaceutical RFID Technologies Market ($m), 2010-2015

Table 5.7 Pharmaceutical RFID Technologies Market ($m), 2016-2021

Table 5.8 Pharmaceutical Taggants Market ($m), 2010-2015

Table 5.9 Pharmaceutical Taggants Market ($m), 2016-2021

Table 5.10 Pharmaceutical Hologram/OVD Market ($m), 2010-2015

Table 5.11 Pharmaceutical Hologram/OVD Market ($m), 2016-2021

Table 5.12 Pharmaceutical Security Inks Market ($m), 2010-2015

Table 5.13 Pharmaceutical Security Inks Market ($m), 2016-2021

Table 5.14 Pharmaceutical Watermarks Market ($m), 2010-2015

Table 5.15 Pharmaceutical Watermarks Market ($m), 2016-2021

Table 6.1 Sales ($m) of Anti-counterfeiting Technologies in Leading National Markets, 2010

Table 6.2 The US Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.3 The US Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 6.4 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2010-2021

Table 6.5 The European Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.6 The European Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 6.7 The Japanese Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.8 The Japanese Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 6.9 The Canadian Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.10 The Canadian Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 6.11 The Chinese Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.12 The Chinese Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 6.13 The Indian Anti-counterfeiting Technologies Market ($m), 2010-2015

Table 6.14 The Indian Anti-counterfeiting Technologies Market ($m), 2016-2021

Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2011

Table 9.1 Pharmaceutical Anti-counterfeiting Technologies Market ($m), 2011-2021

Table 9.2 Promising Anti-counterfeiting Technologies, 2011

List of Figures

Figure 2.1 Worldwide Incidents of Drug Counterfeiting, 2002-2009

Figure 2.2 Flow Chart of the Route Taken by Counterfeit Drugs Entering the Legal Supply Chain 

Figure 5.1 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2010-2021

Figure 5.2 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2010

Figure 5.3 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2015

Figure 5.4 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2021

Figure 5.5 International Patent Applications for RFID Technologies by Country of Origin (%), 2000-2010

Figure 5.6 Pharmaceutical RFID Technologies Market ($m), 2010-2015

Figure 5.7 Pharmaceutical RFID Technologies Market ($m), 2016-2021

Figure 5.8 Pharmaceutical Taggants Market ($m), 2010-2015

Figure 5.9 Pharmaceutical Taggants Market ($m), 2016-2021

Figure 5.10 Pharmaceutical Hologram/OVD Market ($m), 2010-2015

Figure 5.11 Pharmaceutical Hologram/OVD Market ($m), 2016-2021

Figure 5.12 Pharmaceutical Security Inks Market ($m), 2010-2015

Figure 5.13 Pharmaceutical Security Inks Market ($m), 2016-2021

Figure 5.14 Pharmaceutical Watermarks Market ($m), 2010-2015

Figure 5.15 Pharmaceutical Watermarks Market ($m), 2016-2021

Figure 6.1 Sales ($m) of Anti-counterfeiting Technologies in Leading National Markets, 2010

Figure 6.2 The US Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 6.3 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2010

Figure 6.4 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2015

Figure 6.5 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2021

Figure 6.6 The European Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 6.7 The Japanese Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 6.8 The Canadian Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 6.9 The Chinese Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 6.10 The Indian Anti-counterfeiting Technologies Market ($m), 2010-2021

Figure 9.1 Pharmaceutical Anti-counterfeiting Technologies Market ($m), 2011-2021

Figure 10.1 World Anti-counterfeiting Technologies Market ($bn), 2010-2015

Companies Listed

3M

Ahura Scientific

Alfred P. Sloan Foundation

Alien Technology

Altegrity Risk International

AND Automation

Anvisa

Applied DNA Sciences

ARmark Authentication Technologies 

AstraZeneca

Australian Therapeutic Goods Administration 

Authentix

Avery Dennison

Axway

Camdata

Capsugel

Center for Medicine in the Public Interest

Cellular Bioengineering 

CFC International

Colorcon

Cortegra 

Covectra

Domino

Drugs Standard Control Organization

DuPont

Eli Lilly

Everest Holovisions

European Alliance for Access to Safe Medicines

European Commission

European Union

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Parliament

International Federation of Pharmaceutical Manufacturers & Associations

Food and Drug Administration (FDA)

FreightWatch 

GIS

GlaxoSmithKline (GSK)

GS1

Heidelberg 

Hewlett-Packard

Hologram Industries

Holomex

Image Solutions

Ingenia Technology

Inksure Technologies

Intermec

International Criminal Police Organization (INTERPOL)

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

International Hologram Manufacturers Association

International Ink Company

Impinj

Johnson & Johnson

Kodak

Massachusetts Institute of Technology (MIT)

Medicines and Healthcare products Regulatory Agency (MHRA)

Menasha 

Merck & Co.

MicroTag Temed

Microtrace Solutions

Motorola

NanoGuardian

NanoInk

Nanotech Security Corp

National Agency for Food and Drug Administration and Control

National Association of Boards of Pharmacies

Neri Labels

Nokia

Novartis

Novavision

Original1

Pacific Holographics

Parelec

PAREXEL

Pera Innovation 

Pfizer

Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceutical Security Institute (PSI) 

PricewaterhouseCoopers

Quality Brands Protection Committee 

Reckitt Benckiser 

Royal Pharmaceutical Society of Great Britain

Samsung

Sanofi-Aventis

Savi Technology

SICPA

Siemens

Simon Fraser University

Sun Chemical

Symbol Technologies

Systech

Tagsys RFID

Texas Instruments

Thermo Fisher Scientific 

TruTag Technologies

United States Congress

United States Federal Government

United States Pharmacopeia 

United Nations

WISeKey

World Customs Organization (WCO) 

World Health Organization (WHO)

World Intellectual Property Organization (WIPO)

Zebra Technologies

To order this report:

Navigation Systems Industry: Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021

Navigation Systems Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com